NEW YORK (GenomeWeb) – Indian genomics testing firm Positive Bioscience announced today a partnership with Myriad Genetics to offer molecular diagnostic testing in that country. 

As part of the deal, Myriad will make available its tests covering nine cancers. They include BRACAnalysis to identify the risk of breast and ovarian cancer; Colaris to identify hereditary colorectal cancer; and myRisk, which assesses the risk of developing breast, prostate, endometrial, melanoma, pancreatic, colorectal, gastric, and ovarian cancer. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

In Science this week: in vitro generation of human reproductive cells, and more.